BURCAR ALISON D 4

Accession 0001189727-18-000010

CIK 0000883984other

View on SEC.gov Company Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 6:14 PM ET

Size

41.3 KB

Accession

0001189727-18-000010

Insider Transaction Report

Form 4

Period: 2018-06-18

ICU MEDICAL INC/DEICUI

BRUMMETT BURCAR ALISON

Vice President Marketing

Transactions

Sale
Common Stock
2018-06-18$302.75/sh−5,735$1,736,271→ 4,174 total
Exercise of In-Money
Common Stock
2018-06-18$58.79/sh+17,108$1,005,779→ 21,311 total
Sale
Common Stock
2018-06-18$304.73/sh−412$125,549→ 17,399 total
Sale
Common Stock
2018-06-18$305.90/sh−191$58,427→ 17,108 total
Sale
Common Stock
2018-06-19$301.84/sh−26,973$8,141,530→ 5,274 total
Exercise of In-Money
Common Stock
2018-06-20$58.79/sh+21,169$1,244,526→ 21,169 total
Sale
Common Stock
2018-06-20$300.73/sh−5,294$1,592,065→ 15,875 total
Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-06-19−34,747→ 23,145 total
Exercise: $58.79Exp: 2024-02-24→ Common Stock (34,747 underlying)
Sale
Common Stock
2018-06-18$305.90/sh−100$30,590→ 17,299 total
Sale
Common Stock
2018-06-18$301.56/sh−7,199$2,170,930→ 9,909 total
Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-06-18−17,108→ 57,892 total
Exercise: $58.79Exp: 2024-02-24→ Common Stock (17,108 underlying)
Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-06-20−21,169→ 1,976 total
Exercise: $58.79Exp: 2024-02-24→ Common Stock (21,169 underlying)
Sale
Common Stock
2018-06-18$304.16/sh−1,800$547,488→ 17,811 total
Sale
Common Stock
2018-06-18$303.40/sh−1,977$599,822→ 2,197 total
Sale
Common Stock
2018-06-18$304.65/sh−2,197$669,316→ 0 total
Sale
Common Stock
2018-06-19$302.27/sh−5,274$1,594,172→ 0 total
Sale
Common Stock
2018-06-20$302.50/sh−2,125$642,813→ 0 total
Exercise of In-Money
Common Stock
2018-06-19$58.79/sh+34,747$2,042,776→ 34,747 total
Sale
Common Stock
2018-06-19$300.20/sh−2,500$750,500→ 32,247 total
Sale
Common Stock
2018-06-20$301.66/sh−13,750$4,147,825→ 2,125 total
Sale
Common Stock
2018-06-18$302.93/sh−1,700$514,981→ 19,611 total

Footnotes (17)

[F1]These securities are Restricted Stock Units.
[F10]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.15 to $305.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F11]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.55, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F12]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.10 to $302.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F13]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.13 to $302.40, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F14]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.20 to $301.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F15]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.30 to $302.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F16]Options exercisable in four equal annual cumulative installments commencing one year after the grant date.
[F17]Transaction is the exercise of a derivative security; see Column 2.
[F2]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.50 to $303.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F3]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.55 to $304.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F4]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.60 to $304.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F5]All shares sold were sold at the exact price disclosed.
[F6]Shares were previously acquired through the Registrant's Employee Stock Purchase Plan.
[F7]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F8]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.05 to $303.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F9]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.10 to $304.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ICU MEDICAL INC/DE

CIK 0000883984

→

Entity typeother

Related Parties

filerCIK 0001189727

Filing Metadata

Form type: 4
Filed: Jun 19, 8:00 PM ET
Accepted: Jun 20, 6:14 PM ET
Size: 41.3 KB

View on SEC.gov